Select your language

Nucleus Smart App

By Cochlear

The Nucleus Smart App is specifically designed for cochlear implant users with a Cochlear™ Nucleus® 7 or Kanso 2 sound processor. The Nucleus Smart App allows the patient to adjust their sound processor settings in different environments directly, using a compatible Apple or Android™ device. In consultation with their clinician, the Nucleus Smart App allows the patient to activate Remote Check, a convenient, at-home testing tool that allows them to complete a series of tests that checks their hearing health and device in a similar way to those typically conducted during routine, in-clinic appointment.

Level 2

I submitted a reimbursement request to NIHDI, which is eligible.

Downloads

Languages

DE EN ES FR IT NL
General description
Additional info
Media

General description (provided by company)

Main purpose

The Nucleus® Smart App is designed specifically for the Nucleus 7 and Kanso 2 Sound Processors to provide a convenient and easy way to tailor hearing to personal preferences, all from a compatible Apple or Android smartphone* or Apple Watch®^.
With the Nucleus Smart App, it is possible to:
• Start wireless streaming from Cochlear True Wireless™ accessories;
• Fine tune a patient’s hearing experience by adjusting master bass, volume and treble;
• Set up notifications to alert the patient if the coil is off;
• Access personalised hearing information with the Hearing Tracker;
• Quickly change programs or volume and check battery life without carrying a separate
Remote Control;
• Get help finding the sound processor if it is misplaced;
• Complete a Remote Check appointment, which is a convenient, at-home testing tool that allows patients to complete a series of tests that are similar to those typically conducted during routine, in-clinic appointment for individuals with a cochlear implant. Remote Check will only be visible in the recipient’s Nucleus Smart App menu if their clinician has assessed their suitability for remote support and have enrolled the individual into the Remote Check program. In addition, the clinician will determine which combination of Remote Check tests assigned to the patient. The Clinician is able to access and review the test results through a secure Portal and inform the patient of the outcome via the Nucleus Smart App.

Target audience

Cochlear users having a Nucleus 7 or Kanso 2 sound processor

Approach

The cochlear implant recipient will download the Nucleus Smart App from their iOS or Android device and create a username and password. Once the account has been verified, the patient can pair their sound processors to the app and subsequently be able to access the features mentioned previously. If the patient is happy to be enrolled into Remote Check, the clinician enrols them via the portal and this allows access to Remote Check via the App. The patient then has to consent to their test data being shared with their clinic and to the terms and conditions. They cannot proceed unless consent is granted. The patient can then complete a Remote Check appointment and submit the results for review.
The Remote Check appointment allows the patient to:
1) Take photos of their implant site
2) Complete a questionnaire regarding their hearing performance
3) Complete a hearing test
4) Complete a speech in noise test
5) Check the function of their device (implant and sound processor)
6) Upload their usage data

Connectivity to sensors and platforms

The application must be connected to a Nucleus 7 or Kanso 2 sound processor (Cochlear implant)

Financing and pricing model

The Nucleus Smart App is a free app to download for people with a Nucleus 7 or Kanso 2 sound processor together with a compatible device.
The Remote Check feature will only be visible in the recipient’s Nucleus Smart App menu if their clinician has assessed their suitability for remote support and have enrolled the individual into the Remote Check program. In addition, the clinician will determine which combination of Remote Check tests assigned to the patient. Remote Check will be offered at a suitable cost. This will be determined in level 3 of the procedure determined on www.mhealthbelgium.be where we will prove the social economic evidence of Remote Check.

Pathology

Ear / Nose / Throat

Functions

Remote Clinical Monitoring

Users

Everyone Child Teen Men Women Elderly Clinicians

Additional info

This app temporarily, until October 1, 2024, still carries the old M2 label because the requested ICT criteria were met. For now, no reimbursement request has been submitted for this app so it would no longer fall under level M2 in the new model.

Compliance to M2 criteria

Reimbursement request

Self declaration to 6 ICT criteria

Criterion 1: GDPR app category

1 (no processing of personal data) 2 (processing of personal data) 3 (processing of sensitive personal data)

Criterion 2: Identification of the user in need of care

through his/her Social Security Identification Number (SSIN) (obliged for applications of GDPR app category 2 or 3, see above) other

Criterion 3: App user authentication

not applicable (only for app category 1) via FAS level 400 (FAS = Federal Authentication Service, More info) company own authentication system fulfilling the M2 requirements (self-declared)

Criterion 4: Verification of therapeutic relationship and informed consent

not applicable via eHealth platform user and access management system IAM (More info) via company own database fulfilling the M2 requirements (self-declared)

Criterion 5: Applied interoperability standards

KMEHR (More info) HL7 CDA (More info) HL7 FHIR (More info) SNOMED-CT (More info) Other

Criterion 6: GDPR compliance

comply with the principles of (stated in article 5 of the GDPR)
  • lawfulness, fairness and transparency
  • purpose limitation
  • data minimisation
  • accuracy
  • storage limitation
  • integrity and confidentiality
honour the rights of the data subject (as mentioned in Chapter III of GDPR) comply with the special provision on the processing of sensitive personal data (obliged for applications of GDPR app category 3, see above) carried out a data protection impact assessment (according to articles 35 and 36 of GDPR)

Extra: Secured Messaging

not applicable via eHealth platform’s eHealth Box (More info)

Compliance to M1 criteria

CE certification

Download document Granted by TüV SUD Assessed and certified meeting the requirements of:
Medical Device Directive: MDD 93/42/EEC (old regulation) Medical Device Regulation: MDR 2017/745 (new regulation)
Certificate granted on 12/06/2018 Certificate valid till 09/05/2022 Class type of medical device (More info): 2A
ISO Standards:
ISO 13485 Quality Management Systems for Medical Devices (on company level) ISO 14155 Clinical Investigations of Medical Devices in Human Subjects ISO 14971 Risk Management of Medical Devices ISO 27000 series: Information Security Management Systems ISO 62304 Medical Device Software Lifecycle Processes ISO 62366 Application of Usability Engineering to Medical Devices

FAMHP registration and notification

Company registration number at FAMHP: 72100 Product identification code at FAMHP: 832154

General Data Protection Regulation (More info)

Company declares explicitly to be compliant with GDPR rules Company declares that the data are stored in EU only

Reference publication

Remote Check Test Battery for Cochlear Implant Recipients: Proof of Concept Study
Saji Maruthurkkaraa*, Agnes Allenb, Helen Cullingtonc, Joanne Muffd, Komal Arorae, Susan Johnsonf,
Submitted to International Journal of Audiology Nov 2020
Remote Check for asynchronous remote monitoring and triage of cochlear implant recipients
Saji Maruthurkkaraa*, Sasha Casea and Riaan Rottiera
Submitted to Ear & Hearing Dec 2020
Recipient Feedback Study: Project Elon Questionnaire Data on File 2020.
Remote Check was initially evaluated through a multi-centre study as a proof of concept involving clinicians from 6 Cochlear Implant Centres and approximately 100 cochlear implant recipients. This resulted in the submission to IJA (referenced above). The study demonstrated that the tests used were both usable and sufficiently sensitive to identify over 96% of issues that were also identified by a face to face clinical appointment. The App was then developed in-house in consultation with app developers, audiologists, recipients and psychologists to ensure a user-friendly interface was developed. Remote Check was then evaluated by recipients for user experience and reliability resulting in the submission to Ear and Hearing (referenced above) and the Project Elon recipient feedback. Since receiving CE mark in 2018, the app has undergone extensive evaluation phase involving 60 clinics across 13 countries (8 within the EU) and now has over 1700 cochlear implant patients enrolled (>700 in the EU). Remote Check also received FDA approval in April 2020 and a national design award in 2019.

User instructions

The Nucleus Smart App is compatible with iPhone 5 (or later) and sixth generation iPod devices (or later) running iOS 11.0 or later. To use the Nucleus Smart App on Android mobile devices, Android 5.0 (Lollipop) or later must be installed. The device must also support Bluetooth 4.0 or later. Verified devices can be found at http://www.nucleussmartapp.com/android.
Before using the Nucleus Smart App, the compatible mobile device must be paired to a CI-patient’s Nucleus 7 or Kanso 2 sound processor.

Components of the application

Native app

Complaints handling

Media

Screenshot6 Screenshot2 Screenshot3